1. Does sacral nerve stimulation improve global pelvic function in women?
- Author
-
Stephen Radley, H. Wadhawan, Georgina Jones, S. R. Brown, L. W. Wheldon, and A. M. Jadav
- Subjects
medicine.medical_specialty ,Urinary system ,Electric Stimulation Therapy ,Pelvic Floor Disorders ,Pelvic Organ Prolapse ,Pelvic floor dysfunction ,Surveys and Questionnaires ,Internal medicine ,medicine ,Humans ,Irritable bowel syndrome ,Gynecology ,Pelvic floor ,Sacrococcygeal Region ,business.industry ,Gastroenterology ,Middle Aged ,medicine.disease ,body regions ,Sexual Dysfunction, Physiological ,Implantable Neurostimulators ,Spinal Nerves ,Treatment Outcome ,Urinary Incontinence ,Sexual dysfunction ,medicine.anatomical_structure ,Overactive bladder ,Sex life ,Vaginal Pain ,Quality of Life ,Female ,medicine.symptom ,business ,Fecal Incontinence - Abstract
Aim Many women undergoing sacral neuromodulation for faecal incontinence have coexisting pelvic floor dysfunction. We used a global pelvic-floor assessment questionnaire to evaluate the effect of sacral neuromodulation on non-bowel related symptomatology. Method The electronic Personnel Assessment Questionnaire – Pelvic Floor (ePAQ-PF) is a validated Web-based electronic pelvic floor questionnaire. Women with faecal incontinence underwent assessment using the ePAQ. Pre- and poststimulator data were analysed over a 4.5-year period. Results Forty-three women (mean age 56.5 years; median follow up 6.8 months) were included. All (100%) had urinary symptoms, 81.4% had vaginal symptoms and 85.7% described some sexual dysfunction. There was a significant improvement in faecal incontinence and in bowel-related quality of life (P
- Published
- 2013
- Full Text
- View/download PDF